Naughton M, Fahy J, FitzGerald M X
Department of Respiratory Medicine, St. Vincent's Hospital, University College Dublin Medical School, Ireland.
Chest. 1993 Jan;103(1):162-5. doi: 10.1378/chest.103.1.162.
Chronic eosinophilic pneumonia (CEP) is a rare disorder of unknown etiology characterized by striking systemic and pulmonary manifestations such as fever, weight loss, blood eosinophilia, characteristic fluffy peripheral opacities on chest radiograph, and a prompt response to corticosteroid therapy. While the initial phase has been well documented, there is very limited information concerning the long-term natural history and treated course of this condition. We report the clinical and laboratory findings together with the long-term follow-up data on 12 patients with classic CEP who were followed up for a mean of 10.2 years (range, 4 to 13 years). The most striking feature of the long-term follow-up was the occurrence of relapses of CEP (often on multiple occasions) when corticosteroid therapy was discontinued or the dose was tapered. In those nine patients in whom steroid withdrawal was commenced, there was a clinical, hematologic, and radiologic relapse in seven (58 percent). However, prompt reinstitution of therapy led to a rapid resolution of symptoms. By contrast, two patients (17 percent) showed no evidence of relapse when steroid therapy was discontinued. A further three patients (25 percent) are maintained on a regimen of low-dose steroid therapy with no episodes of relapse. Reassuringly, all 12 patients are well at the end of a long period of follow-up. These data suggest that the long-term prognosis for patients with CEP is excellent but the majority will require long-term low-dose oral corticosteroid therapy in order to prevent relapse.
慢性嗜酸性粒细胞性肺炎(CEP)是一种病因不明的罕见疾病,其特征为显著的全身和肺部表现,如发热、体重减轻、血液嗜酸性粒细胞增多、胸部X线片显示特征性的周边模糊片状阴影,以及对皮质类固醇治疗迅速起效。虽然疾病的初始阶段已有充分记录,但关于该疾病的长期自然病程和治疗过程的信息非常有限。我们报告了12例典型CEP患者的临床和实验室检查结果以及长期随访数据,这些患者的平均随访时间为10.2年(范围4至13年)。长期随访最显著的特征是,当停用皮质类固醇治疗或减少剂量时,CEP会复发(常为多次复发)。在开始减停激素的9例患者中,7例(58%)出现了临床、血液学和影像学复发。然而,迅速恢复治疗可使症状迅速缓解。相比之下,2例患者(17%)在停用激素治疗时未出现复发迹象。另外3例患者(25%)维持低剂量激素治疗方案,未出现复发。令人欣慰的是,所有12例患者在长期随访结束时情况良好。这些数据表明,CEP患者的长期预后良好,但大多数患者需要长期低剂量口服皮质类固醇治疗以预防复发。